Affordable Access

Publisher Website

A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline.

Authors
Type
Published Article
Journal
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Publication Date
Volume
71
Issue
17
Pages
1457–1461
Identifiers
DOI: 10.2146/ajhp130474
PMID: 25147169
Source
Medline

Abstract

A 67-year-old man developed profound neutropenia and agranulocytosis after three weeks of high-dose ceftaroline therapy for the treatment of MRSA septic arthritis. His neutropenia resolved after ceftaroline discontinuation and treatment with an alternative antibiotic.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments